Skip to main content

Peer Review reports

From: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Original Submission
6 May 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 May 2021 Reviewed Reviewer Report
4 Jun 2021 Reviewed Reviewer Report - Jose Oñate
11 Jun 2021 Author responded Author comments - Rodrigo Zoni
Resubmission - Version 3
11 Jun 2021 Submitted Manuscript version 3
15 Jun 2021 Author responded Author comments - Rodrigo Zoni
Resubmission - Version 4
15 Jun 2021 Submitted Manuscript version 4
Publishing
17 Jun 2021 Editorially accepted
2 Jul 2021 Article published 10.1186/s12879-021-06348-5

You can find further information about peer review here.

Back to article page